Product Information
XELSTRYM 13.5 MG/9 HR PATCH is a brand product labeled by Noven Therapeutics, LLC, priced at $16.2687 per EA under NDC 68968021503. Its NADAC has been published 110 times since Jul 17, 2024.
FDA first approved this application on Mar 22, 2022.
Strength
13.5 mg/1
Manufacturer
Noven Therapeutics, LLCNDC
68968021503
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
DEXTROAMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA215401FDA Approved
3/22/2022
On Market Since
5/15/2023
Pharmacological Classes
Price Statistics
The NADAC for XELSTRYM 13.5 MG/9 HR PATCH has been published 110 times since Jul 17, 2024, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2687 per EA |
|---|---|
| All-time high | $16.3585 (May 14, 2025) |
| All-time low | $15.5744 (Aug 21, 2024) |
| 52-week high | $16.3252 |
| 52-week low | $16.2687 |
| Median price | $16.3044 |
| Average price | $16.1563 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 110 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the DEXTROAMPHETAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XELSTRYM 13.5 MG/9 HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for XELSTRYM 13.5 MG/9 HR PATCH, manufactured by Noven Therapeutics, LLC, is $16.2687 per EA (NDC 68968021503), effective Aug 19, 2026.
How has the price of XELSTRYM 13.5 MG/9 HR PATCH changed over time?
Over the history we have for it, the NADAC for XELSTRYM 13.5 MG/9 HR PATCH has risen 4.4%. It has been tracked across 110 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for XELSTRYM 13.5 MG/9 HR PATCH?
Since Jul 17, 2024, the NADAC for XELSTRYM 13.5 MG/9 HR PATCH has ranged from a low of $15.5744 (Aug 21, 2024) to a high of $16.3585 (May 14, 2025), with a median of $16.3044 per EA.
Are there cheaper alternatives to XELSTRYM 13.5 MG/9 HR PATCH?
No other NADAC-published product currently shares the active ingredient and strength of XELSTRYM 13.5 MG/9 HR PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures XELSTRYM 13.5 MG/9 HR PATCH?
XELSTRYM 13.5 MG/9 HR PATCH (NDC 68968021503) is labeled by Noven Therapeutics, LLC, and CMS classifies it as a brand product.